Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-367195
Filing Date
2015-11-05
Accepted
2015-11-05 07:14:40
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d13058d10q.htm 10-Q 447358
2 EX-31.1 d13058dex311.htm EX-31.1 5402
3 EX-31.2 d13058dex312.htm EX-31.2 5613
4 EX-32.1 d13058dex321.htm EX-32.1 3355
5 EX-32.2 d13058dex322.htm EX-32.2 3351
  Complete submission text file 0001193125-15-367195.txt   4297895

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dnai-20150930.xml EX-101.INS 680841
7 XBRL TAXONOMY EXTENSION SCHEMA dnai-20150930.xsd EX-101.SCH 55415
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dnai-20150930_cal.xml EX-101.CAL 64220
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dnai-20150930_def.xml EX-101.DEF 265197
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dnai-20150930_lab.xml EX-101.LAB 470735
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dnai-20150930_pre.xml EX-101.PRE 355827
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
ProNAi Therapeutics Inc (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 151198767
SIC: 2834 Pharmaceutical Preparations